When is active surveillance not really active surveillance?

A story that got wide coverage yesterday (in the cancer-specific media, at least) said that “research published online in the Journal of Clinical Oncology suggests that ‘active surveillance for clinical stage I (CSI) testicular cancer leads to excellent outcomes’.” … READ MORE …

Is baseline free serum T a factor in appropriate management on active surveillance?

Analysis of data from a cohort of 154 Chilean men with prostate cancer, all being monitored on active surveillance, suggests that free serum testosterone levels (but not total testosterone levels) may be able to help to predict which of these men will go on to need active treatment. … READ MORE …

The choice of active surveillance: patient and partner perceptions

Two recent papers in the journal Psycho-oncology offer us interesting insights into patients’ (and their partners’) current perceptions about the role of active surveillance in the management of low-risk, localized prostate cancer. … READ MORE …

Can the phi test accurately predict who should go on active surveillance?

In more data reported at ASCO yesterday afternoon, we got the first real look at what appears to be a helpful study designed to evaluate whether the Beckman Coulter Prostate Health Index (or phi) test is really able to identify men who are good candidates for active surveillance. … READ MORE …

Other interesting active surveillance data from the AUA meeting in Orlando

In addition to the Sunnybrook data already reported today, three significant other studies presented at the AUA meeting have provided us with valuable information on the practical application of active surveillance. … READ MORE …

Formal update on Sunnybrook active surveillance data at AUA annual meeting

Over the weekend, Klotz et al. provided interesting new information in the third and most recent, formal update of the prospective data from the active surveillance series being monitored at Sunnybrook Cancer Center in Toronto, Canada. … READ MORE …

What’s being presented at ASCO this year: III

Another interesting presentation being made at the ASCO annual meeting this year will be the first report on a series of nearly 400 patients who did not conform to what would normally be considered a series of sound criteria for low risk disease. These patients all elected, as individuals, to go on actiuve surveillance despite their higher than average risk for progression. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,169 other followers